China is forging ahead to conduct human clinical trials of treatments using the CRISPR gene-editing tool, the Wall Street Journal reports. The first CRISPR trial began in China in 2015, while the first outside of China, likely to be at the University of Pennsylvania, has yet to begin, it adds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.